News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Guardant Health, Inc.
< Previous
1
2
3
4
5
Next >
Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
February 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence
January 17, 2024
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results
January 08, 2024
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
January 08, 2024
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
HKMPY
OTC
Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer
January 02, 2024
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford
December 21, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Announces Tentative Date of FDA Advisory Panel Review of Shield™ Blood Test
December 19, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities
December 04, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection
November 30, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 15, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to Appeal Federal District Court Verdict
November 15, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
November 06, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to Participate in Upcoming November Investor Conferences
November 03, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health, Flatiron Health Announce Integration of Guardant Genomic Profiling Tests Into OncoEMR® Platform
October 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer
October 23, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023
October 16, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Receives Coverage for Guardant Reveal™ from Geisinger Health Plan
September 06, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations
September 05, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
September 01, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to Host Investor Day on September 7, 2023
August 17, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance
August 03, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research
August 01, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health receives first commercial payor coverage for Guardant Reveal™ test from Blue Cross and Blue Shield of Louisiana
July 20, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to Report Second Quarter 2023 Financial Results on August 3, 2023
July 12, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan
July 05, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting
May 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health to Participate in Upcoming June Investor Conferences
May 26, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock
May 22, 2023
From
Guardant Health, Inc.
Via
Business Wire
Tickers
GH
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close